Cognex Corporation (CGNX) Shares Bought by Thrivent Financial For Lutherans
Thrivent Financial For Lutherans raised its holdings in shares of Cognex Corporation (NASDAQ:CGNX) by 1.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 69,278 shares of the scientific and technical instruments company’s stock after purchasing an additional 1,150 shares during the quarter. Thrivent Financial For Lutherans owned 0.08% of Cognex Corporation worth $5,881,000 at the end of the most recent reporting period.
Several other large investors have also added to or reduced their stakes in CGNX. BlackRock Inc. lifted its position in shares of Cognex Corporation by 16,264.7% during the first quarter. BlackRock Inc. now owns 6,656,024 shares of the scientific and technical instruments company’s stock worth $558,773,000 after purchasing an additional 6,615,351 shares during the last quarter. Ameriprise Financial Inc. lifted its position in shares of Cognex Corporation by 126.7% during the second quarter. Ameriprise Financial Inc. now owns 2,342,312 shares of the scientific and technical instruments company’s stock worth $198,864,000 after purchasing an additional 1,309,047 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Cognex Corporation by 86.7% during the first quarter. Goldman Sachs Group Inc. now owns 888,783 shares of the scientific and technical instruments company’s stock worth $74,613,000 after purchasing an additional 412,652 shares during the last quarter. American Century Companies Inc. bought a new stake in shares of Cognex Corporation during the second quarter worth $31,281,000. Finally, Vanguard Group Inc. lifted its position in shares of Cognex Corporation by 5.0% during the first quarter. Vanguard Group Inc. now owns 6,574,861 shares of the scientific and technical instruments company’s stock worth $551,959,000 after purchasing an additional 311,769 shares during the last quarter. Institutional investors and hedge funds own 87.25% of the company’s stock.
Shares of Cognex Corporation (NASDAQ:CGNX) opened at 113.43 on Monday. The company has a 50 day moving average price of $105.58 and a 200 day moving average price of $92.16. Cognex Corporation has a 12-month low of $49.68 and a 12-month high of $115.35. The company has a market capitalization of $9.82 billion, a P/E ratio of 51.82 and a beta of 1.40.
Cognex Corporation (NASDAQ:CGNX) last released its quarterly earnings results on Monday, July 31st. The scientific and technical instruments company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.55 by $0.08. The business had revenue of $172.90 million during the quarter, compared to analysts’ expectations of $169.79 million. Cognex Corporation had a return on equity of 19.51% and a net margin of 33.10%. The company’s revenue was up 17.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.50 EPS. Equities analysts anticipate that Cognex Corporation will post $2.55 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Friday, September 1st. Stockholders of record on Friday, August 18th were issued a dividend of $0.085 per share. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.30%. The ex-dividend date was Wednesday, August 16th. Cognex Corporation’s dividend payout ratio is presently 15.60%.
Several analysts have recently weighed in on CGNX shares. Cowen and Company reiterated a “buy” rating and set a $100.00 target price on shares of Cognex Corporation in a research report on Tuesday, July 11th. Zacks Investment Research upgraded Cognex Corporation from a “hold” rating to a “buy” rating and set a $95.00 target price for the company in a research report on Tuesday, July 4th. BidaskClub downgraded Cognex Corporation from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 30th. Finally, Wolfe Research upgraded Cognex Corporation from a “market perform” rating to an “outperform” rating in a research report on Monday, August 14th. Five analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. Cognex Corporation currently has a consensus rating of “Buy” and an average price target of $82.75.
COPYRIGHT VIOLATION WARNING: This news story was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/09/25/cognex-corporation-cgnx-shares-bought-by-thrivent-financial-for-lutherans.html.
In related news, Director Patrick Alias sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, September 12th. The stock was sold at an average price of $111.31, for a total transaction of $556,550.00. Following the completion of the transaction, the director now directly owns 5,000 shares in the company, valued at approximately $556,550. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Robert Willett sold 66,759 shares of the firm’s stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $104.58, for a total value of $6,981,656.22. Following the transaction, the chief executive officer now owns 9,468 shares of the company’s stock, valued at $990,163.44. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 126,750 shares of company stock valued at $13,242,726. Company insiders own 5.60% of the company’s stock.
Cognex Corporation Company Profile
Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX).
Receive News & Ratings for Cognex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex Corporation and related companies with MarketBeat.com's FREE daily email newsletter.